Abstract
Paracrine and juxtacrine signaling via proteins expressed on the cell surface are an integral part of metazoan biology. More than one-half billion years ago epidermal growth factor (EGF) and its cognate receptor formed a functional binding partnership, which has been conserved through evolution in essentially all eubilaterate members of the animal kingdom. Early chordates spawned offspring of these seminal genes to begin the creation of new gene families and an expanded cell-cell signaling network, which included the Neuregulin (NRG) ligands and the erbB receptors. First appearance of ancestral NRG, represented in a NRG4-like gene in the lancelet Branchiostoma floridae, appears to have: 1) occurred in the common chordate ancestor prior to the divergence of lancelets (amphioxus), and; 2) antedated the formation of the receptor gene family. Orthologues of NRG1 and multiple erbB receptors found in the sea lamprey Petromyzon marinus suggest that several key events, which were required to expand and diversify these gene families, occurred in the common ancestor of agnathostomes and jawed vertebrates. These important inventions surely played major roles in the acquisition of multiple apomorphic features of the emerging vertebrate lineage.
Keywords: Binding, erbB receptor, lamprey, lancelet.
Current Pharmaceutical Design
Title:Neuregulin Signaling in Pieces-Evolution of the Gene Family
Volume: 20 Issue: 30
Author(s): Mark A. Marchionni
Affiliation:
Keywords: Binding, erbB receptor, lamprey, lancelet.
Abstract: Paracrine and juxtacrine signaling via proteins expressed on the cell surface are an integral part of metazoan biology. More than one-half billion years ago epidermal growth factor (EGF) and its cognate receptor formed a functional binding partnership, which has been conserved through evolution in essentially all eubilaterate members of the animal kingdom. Early chordates spawned offspring of these seminal genes to begin the creation of new gene families and an expanded cell-cell signaling network, which included the Neuregulin (NRG) ligands and the erbB receptors. First appearance of ancestral NRG, represented in a NRG4-like gene in the lancelet Branchiostoma floridae, appears to have: 1) occurred in the common chordate ancestor prior to the divergence of lancelets (amphioxus), and; 2) antedated the formation of the receptor gene family. Orthologues of NRG1 and multiple erbB receptors found in the sea lamprey Petromyzon marinus suggest that several key events, which were required to expand and diversify these gene families, occurred in the common ancestor of agnathostomes and jawed vertebrates. These important inventions surely played major roles in the acquisition of multiple apomorphic features of the emerging vertebrate lineage.
Export Options
About this article
Cite this article as:
Marchionni A. Mark, Neuregulin Signaling in Pieces-Evolution of the Gene Family, Current Pharmaceutical Design 2014; 20 (30) . https://dx.doi.org/10.2174/1381612819666131125152146
DOI https://dx.doi.org/10.2174/1381612819666131125152146 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Choice of Antihypertensive Treatment in Subjects with Pre-Diabetes. Is There a Dream After the Navigator
Current Vascular Pharmacology Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy Neuroprotection & Mechanism of Ethanol in Stroke and Traumatic Brain Injury Therapy: New Prospects for an Ancient Drug
Current Drug Targets Misoprostol-induced Acute Coronary Syndrome in a Premenopausal Woman: A Case Report with Literature Review
Current Drug Safety Effects of Folic Acid and Vitamin B12, Alone and in Combination on Cognitive Function and Inflammatory Factors in the Elderly with Mild Cognitive Impairment: A Single-blind Experimental Design
Current Alzheimer Research To Die or Not to Die: That is the Autophagic Question
Current Molecular Medicine The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
Current Diabetes Reviews Nano-antibiotics: A Therapeutic Future
Nanoscience & Nanotechnology-Asia Cardiac Applications for Human Pluripotent Stem Cells
Current Pharmaceutical Design Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets Prevention of Contrast Induced Nephropathy
Current Drug Therapy Repositioning of Drugs in Cardiometabolic Disorders: Importance and Current Scenario
Current Topics in Medicinal Chemistry Cell-based Therapy for Hypertension: Challenges and Perspectives
Current Pharmaceutical Design ATP-Sensitive K+ Channels: Current and Putative Target for the Prevention and Treatment of Cardiovascular Diseases
Vascular Disease Prevention (Discontinued) The Mevalonate Pathway as a Therapeutic Target in the Ph-Negative Chronic Myeloproliferative Disorders
Current Drug Targets Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Current Pharmaceutical Analysis Efficacy and Cardiovascular Safety of Thiazolidinediones
Current Drug Safety The Innate Immune System and Fever under Redox Control: A Narrative Review
Current Medicinal Chemistry Cardiovascular Risk Calculators and their Applicability to South Asians
Current Diabetes Reviews Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review
Recent Patents on Anti-Cancer Drug Discovery